What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
Publications
September, 16 2026
Four years of work. 2,396 patients. And now, one very special milestone: 𝗜𝟯𝗟𝗨𝗡𝗚 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝗡𝗮𝘁𝘂𝗿𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲. 🎉 […]
News
June, 26 2026
🚀 The countdown is on! In few days, the I3LUNG consortium comes together for our Annual Meeting, a key milestone […]
News
June, 25 2026
On Monday, Federica Corso (from our partner and project lead, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) presented the […]